| 000 | 01390 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250512201923.0 | ||
| 264 | 0 | _c19831028 | |
| 008 | 198310s 0 0 eng d | ||
| 022 | _a0165-1781 | ||
| 024 | 7 |
_a10.1016/0165-1781(83)90082-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLevy, M I | |
| 245 | 0 | 0 |
_aGamma-hydroxybutyrate in the treatment of schizophrenia. _h[electronic resource] |
| 260 |
_bPsychiatry research _cMay 1983 |
||
| 300 |
_a1-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aHomovanillic Acid _xcerebrospinal fluid |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxybutyrates _xtherapeutic use |
| 650 | 0 | 4 |
_aHydroxyindoleacetic Acid _xcerebrospinal fluid |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethoxyhydroxyphenylglycol _xcerebrospinal fluid |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aProlactin _xblood |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aSchizophrenic Psychology |
| 650 | 0 | 4 |
_aSodium Oxybate _xtherapeutic use |
| 700 | 1 | _aDavis, B M | |
| 700 | 1 | _aMohs, R C | |
| 700 | 1 | _aTrigos, G C | |
| 700 | 1 | _aMathé, A A | |
| 700 | 1 | _aDavis, K L | |
| 773 | 0 |
_tPsychiatry research _gvol. 9 _gno. 1 _gp. 1-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0165-1781(83)90082-3 _zAvailable from publisher's website |
| 999 |
_c6193591 _d6193591 |
||